Search | TVST | ARVO Journals

Showing 1 – 20 of 88

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Dysregulated natural killer cells mediate RPE dysfunction in early Age-Related Macular Degeneration

Archana Padmanabhan Nair; Sayan Ghosh; Praveen Machiraju; Swaminathan Sethu; Debasish Sinha; Arkasubhra Ghosh

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):570.

ARVO Annual Meeting Abstract June 2024

Elevated Bcat1 in Retinoblastoma tumors enhances BCAA conversion and mediates autophagy modulation for tumor growth

Arkasubhra Ghosh; Keya Katare; Gagan Dudeja

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):466.

ARVO Annual Meeting Abstract June 2024

AI-based clinical stratification using tear film biomarkers in DED to identify sub-clinical disease

Pooja Khamar; Raghav Narashiman; Rohit Shetty; Arkasubhra Ghosh; Swaminathan Sethu

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):411.

ARVO Annual Meeting Abstract June 2024

A pilot study of inflammatory biomarkers in tear film of children with myopia

Tos TJM Berendschot; Shruti Nishanth; Swaminathan sethu; Arkasubhra Ghosh; Govindasamy Kumaramanickavel; Noël Bauer

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2723.

ARVO Annual Meeting Abstract June 2024

Intraocular molecular signature associated with severity, progression, and response to therapy in glaucoma patients

Swaminathan Sethu; Archana Padmanabhan Nair; Sushma Tejwani; Arkasubhra Ghosh

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3320.

ARVO Annual Meeting Abstract June 2024

South Indian Thyroid Eye Disease Study (SITED): Tear biomarkers to predict thyroid eye disease activity

Pratheeba nivean; Swaminathan sethu; Arkasubhra Ghosh; kirthi koka; Tos TJM Berendschot; Govindasamy Kumaramanickavel; Dion Paridaens

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3036.

ARVO Annual Meeting Abstract June 2024

induced pluripotent stem cells derived corneal endothelial cells to model and treat Fuchs endothelial corneal dystrophy

Koushik Chakrabarty; Divyani Nayak; Sharon dsouza; Arkasubhra Ghosh; rohit shetty

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5786.

ARVO Annual Meeting Abstract June 2024

Prediction of disease trajectory using Biomarker based AI classification of DME

Thirumalesh Mochi Basavaraj; Raghav Narashiman; Santosh GopiKrishna Gedde; Swaminathan Sethu; Abhijit Sinha Roy; Arkasubhra Ghosh

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5649.

ARVO Annual Meeting Abstract June 2024

Challenges of tear fluid research in the lab

Arkasubhra Ghosh

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6197a.

ARVO Annual Meeting Abstract June 2023

Correction of Photoreceptor Function and Lipofuscin Deposits in a Model of Stargardt Disease using AAV9 Delivered ABCA4 Hybrid Dual Vectors

Veluchamy Barathi; Sai Bo Bo Tun; Yeo SiaWey; Chitra Gopinath; Arkasubhra Ghosh

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):798.

ARVO Annual Meeting Abstract June 2023

Hyperglycemia-induced miR182-5p drives glycolytic and angiogenic response via depleting FoxO1 in Proliferative Diabetic Retinopathy

Arkasubhra Ghosh; Shaika Shanbagh; Shyam S Chaurasia; santosh Gopikrishna

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1811.

ARVO Annual Meeting Abstract June 2023

Targeting Epigenetic Modifiers to Protect Barrier Integrity in Retinal Pigment Epithelial Cells

Shyam S Chaurasia; Rayne R Lim; Binapani Mahaling; Arkasubhra Ghosh

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2827.

ARVO Annual Meeting Abstract June 2023

Untargeted metabolomics identifies Myristoleolyl Carnitine as a tear based detector for bacterial endophthalmitis

Vrushali Deshpande; Naren Shetty; Samayitree Das; Ramaraj Kannan; Priyanka Sathe; Padmamalini Mahendradas; ROHIT SHETTY; Arkasubhra Ghosh

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4419.

Cornea & External Disease July 2022

Ocular Surface Immune Cell Profiles in Contact Lens–Induced Discomfort

PDF

Archana Padmanabhan Nair; Swaminathan Sethu; Harsha Nagaraj; Vijay Kumar; Sriharsha Nagaraj; Zohra Fadli; Charles Scales; Mike Chemaly; Xiao-Yu Song; Arkasubhra Ghosh; Bailin Liang
TAGS: contact lenses, lens (device), lens, crystalline, ocular surfaces, cytology
Trans. Vis. Sci. Tech.. 2022; 11(7):16. https://doi.org/10.1167/tvst.11.7.16

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2022

Biomarkers from clinic deployable, multiplex, diagnostic test stratifies ocular surface disease and sub-clinical inflammation in patients.

Sailie Shirodkar; Rohit Shetty; Archana Padmanabhan Nair; Pooja Khamar; Swaminathan Sethu; Arkasubhra Ghosh

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):423.

ARVO Annual Meeting Abstract June 2022

Host factors related to SARS-CoV2 infection in the human eye and prophylaxis thereof

Sharon DSouza; Vishnu Suresh Babu; Trailokyanath Panigrahi; Rohit Shetty; Pooja Khamar; Poornachandra B; Swaminathan Sethu; Arkasubhra Ghosh

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):859.

ARVO Annual Meeting Abstract June 2022

Immune profile in patients with COVID-19 associated rhino-orbital-cerebral mucormycosis

Bhavya Gorimanipalli; Archana Padmanabhan Nair; Rohit Shetty; Sanjay Mahajan; Sushma Ananthakrishna; Anjali Kiran; Moupia Goswami; Varshitha Hemanth Vasanthapuram; Raksha Rao; Gairik Kundu; Ajay Krishna Murthy; Gagan Dudeja; Roshmi Gupta; Swaminathan Sethu; Arkasubhra Ghosh

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):856.

ARVO Annual Meeting Abstract June 2022

Novel genes and variants associated with inflammation identified in Keratoconus families

Ramaraj Kannan; Rohit Shetty; Pooja Khamar; Arkasubhra Ghosh

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):507 – A0084.

ARVO Annual Meeting Abstract June 2022

Understanding ocular surface pain based on discordance between symptoms and signs:associating clinical features,imaging,AI and tear molecular profiles.

Gairik Kundu; Rohit Shetty; Arkasubhra Ghosh; Swaminathan Sethu; Abhijit Sinha Roy; Sharon DSouza

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1540 – A0265.

ARVO Annual Meeting Abstract June 2022

Regulation of epithelial to mesenchymal transition (EMT) and chemoresistance in advanced Retinoblastoma tumors by miR-181a

Arkasubhra Ghosh; Vishnu babu

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2339 – A0008.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Dysregulated natural killer cells mediate RPE dysfunction in early Age-Related Macular Degeneration

Elevated Bcat1 in Retinoblastoma tumors enhances BCAA conversion and mediates autophagy modulation for tumor growth

AI-based clinical stratification using tear film biomarkers in DED to identify sub-clinical disease

A pilot study of inflammatory biomarkers in tear film of children with myopia

Intraocular molecular signature associated with severity, progression, and response to therapy in glaucoma patients

South Indian Thyroid Eye Disease Study (SITED): Tear biomarkers to predict thyroid eye disease activity

induced pluripotent stem cells derived corneal endothelial cells to model and treat Fuchs endothelial corneal dystrophy

Prediction of disease trajectory using Biomarker based AI classification of DME

Challenges of tear fluid research in the lab

Correction of Photoreceptor Function and Lipofuscin Deposits in a Model of Stargardt Disease using AAV9 Delivered ABCA4 Hybrid Dual Vectors

Hyperglycemia-induced miR182-5p drives glycolytic and angiogenic response via depleting FoxO1 in Proliferative Diabetic Retinopathy

Targeting Epigenetic Modifiers to Protect Barrier Integrity in Retinal Pigment Epithelial Cells

Untargeted metabolomics identifies Myristoleolyl Carnitine as a tear based detector for bacterial endophthalmitis

Ocular Surface Immune Cell Profiles in Contact Lens–Induced Discomfort

Biomarkers from clinic deployable, multiplex, diagnostic test stratifies ocular surface disease and sub-clinical inflammation in patients.

Host factors related to SARS-CoV2 infection in the human eye and prophylaxis thereof

Immune profile in patients with COVID-19 associated rhino-orbital-cerebral mucormycosis

Novel genes and variants associated with inflammation identified in Keratoconus families

Understanding ocular surface pain based on discordance between symptoms and signs:associating clinical features,imaging,AI and tear molecular profiles.

Regulation of epithelial to mesenchymal transition (EMT) and chemoresistance in advanced Retinoblastoma tumors by miR-181a

To View More...

You must be signed into an individual account to use this feature.